Tamro Group's Nordic Expansion

29 September 1996

- The Tamro Group's hospital and laboratory division is expanding in the Nordic countries and growing in the pharmaceutical distribution area. The recent acquisition of Helgar & Co A/S, a Norwegian company, has strengthened the position of the Tamro group Swedish AB Labassco unit. Labassco bought all Helgar & Co's capital stock, whose laboratory products market share in Norway is nearly 10%. Meantime, Tamro's joint-venture company based in St Petersburg, Pharm Tamda 77, has opened a new bonded warehouse and a distribution warehouse in the city.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight